Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Aslan Pharmaceuticals Ltd ADR (ASLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2018	12-2017	12-2016	12-2006
Cash Flows From Operating Activities
Net Income	-42,171	-39,892	-9,049	N/A
Depreciation Amortization	242	210	76	N/A
Accounts receivable	N/A	1,294	-1,294	N/A
Accounts payable and accrued liabilities	1,417	1,621	2,130	N/A
Other Working Capital	1,197	3,292	1,472	N/A
Other Operating Activity	-154	-642	876	0
Operating Cash Flow	$-39,470	$-34,117	$-5,789	$N/A

Cash Flows From Investing Activities
PPE Investments	-80	-291	-374	N/A
Purchase Of Investment	-11	-36	-69	N/A
Purchase Sale Intangibles	-23,003	-9	-81	N/A
Other Investing Activity	-23,003	-9	-81	0
Investing Cash Flow	$-23,094	$-336	$-524	$N/A

Cash Flows From Financing Activities
Debt Issued	4,060	229	N/A	N/A
Debt Repayment	N/A	N/A	-377	N/A
Common Stock Issued	42,228	33,061	22,224	N/A
Other Financing Activity	-5,389	0	9,141	0
Financing Cash Flow	$40,900	$33,290	$30,987	$N/A

Beginning Cash Position	50,573	51,737	27,062	N/A
End Cash Position	28,909	50,573	51,737	N/A
Net Cash Flow	$-21,664	$-1,164	$24,675	$N/A

Free Cash Flow
Operating Cash Flow	-39,470	-34,117	-5,789	N/A
Capital Expenditure	-80	-291	-374	N/A
Free Cash Flow	-39,550	-34,408	-6,164	0